Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A dual GLP-1 and GIP receptor agonist, such as tirzepatide, stimulates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors
Cancer While there have been concerns that GLP-1 mimics might raise the risk of thyroid and pancreatic cancers, recent research has cast doubt on these worries
Generally speaking, it can improve overall health and wellness by helping you work out more often, recover more quickly from workouts, and provide anti-aging benefits, such as reducing systemic inflammation
some ingredients less relevant without weight loss Not eligible for the 85 free welcome gift promotion Relatively new product
Phase 1a studies in healthy volunteers, published in Diabetes, Obesity and Metabolism in 2023, established the compound's single-dose and multiple-dose pharmacokinetics, confirming a half-life supportive of once-daily dosing, a favorable food-effect profile, and dose-proportional exposure across the tested range
